{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:43:47Z","timestamp":1762868627913,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence nationale de securite du medicament et des produits de sante","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.therap.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T17:37:08Z","timestamp":1633714628000},"page":"405-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss\u00a0\u2013\u00a0An observational study using the EFEMERIS database"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-961X","authenticated-orcid":false,"given":"Cl\u00e9mentine","family":"Vabre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-9554","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Hurault-Delarue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.09.006_bib0095","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2021.09.006_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0029-7844(97)00582-6","article-title":"Alternative therapies for nausea and vomiting of pregnancy","volume":"91","author":"Murphy","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.therap.2021.09.006_bib0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-200059040-00005","article-title":"A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy","volume":"59","author":"Mazzotta","year":"2000","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.therap.2021.09.006_bib0110","doi-asserted-by":"crossref","first-page":"e0219095","DOI":"10.1371\/journal.pone.0219095","article-title":"The French Pregnancy Cohort: Medication use during pregnancy in the French population","volume":"14","author":"B\u00e9rard","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.therap.2021.09.006_bib0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420150108","article-title":"Possible teratogenic effect of phenothiazines in human beings","volume":"15","author":"Rumeau-Rouquette","year":"1977","journal-title":"Teratology"},{"issue":"5","key":"10.1016\/j.therap.2021.09.006_bib0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9378(77)90029-1","article-title":"Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score","volume":"128","author":"Slone","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.therap.2021.09.006_bib0125","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG practice bulletin No. 189: nausea and vomiting of pregnanc","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"year":"2016","series-title":"The management of nausea and vomiting of pregnancy and hyperemesis gravidarum (Green-top Guideline No. 69)","key":"10.1016\/j.therap.2021.09.006_bib0130"},{"key":"10.1016\/j.therap.2021.09.006_bib0135","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00228-009-0647-2","article-title":"Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database","volume":"65","author":"Lacroix","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2021.09.006_bib0140","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/ndt\/gfu325","article-title":"Graphical presentation of confounding in directed acyclic graphs","volume":"30","author":"Suttorp","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.therap.2021.09.006_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.therap.2018.11.014","article-title":"Pharmacoepidemiology in pregnancy","volume":"74","author":"Benevent","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2021.09.006_bib0150","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/jama.2013.278343","article-title":"Metoclopramide in pregnancy and risk of major congenital malformations and fetal death","volume":"310","author":"Pasternak","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2021.09.006_bib0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2021.09.006_bib0160","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/jamainternmed.2016.5641","article-title":"Association of nausea and vomiting during pregnancy with pregnancy loss: a secondary analysis of a randomized clinical trial","volume":"176","author":"Hinkle","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.therap.2021.09.006_bib0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12958-018-0415-1","article-title":"Gestational hormone trajectories and early pregnancy failure: a reassessment","volume":"16","author":"Whittaker","year":"2018","journal-title":"Reprod Biol Endocrinol RBE"},{"issue":"6","key":"10.1016\/j.therap.2021.09.006_bib0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2515\/therapie\/2008064","article-title":"Autom\u00e9dication chez la femme enceinte","volume":"63","author":"Mikou","year":"2008","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2021.09.006_bib0175","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/bdra.23555","article-title":"Birth defects and neonatal morbidity caused by teratogen exposure after the embryonic period","volume":"106","author":"Scheuerle","year":"2016","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.therap.2021.09.006_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:10Z","timestamp":1758567310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0040595721002031"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.006","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss\u00a0\u2013\u00a0An observational study using the EFEMERIS database","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}